Heron Therapeutics, Inc. /De/
HRTX
Revenue
10.05M
▲1.48M▲17.28%
3 Months ChangeAssets
218.14M
▲249.00k▲0.1143%
3 Months ChangeLiabilities
256.08M
▲4.42M▲1.76%
3 Months ChangeFree Cash Flow
-25.12M
▲19.86M▲44.15%
12 Months ChangeRevenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
| Date | Revenue | Cost Of Revenue |
|---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
| Date | Net Profit/Loss |
|---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
| Date | Assets | Liabilities |
|---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
| Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
|---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
| Date | EPS | EPS (Diluted) |
|---|---|---|
Outstanding Shares
Loading...
| Date | Outstanding Shares |
|---|---|
Recent 8-K/10-Q Filings
2024-08-06
Form 10-Q
ID: 0000950170-24-091764
2024-08-06
Form 8-K
ID: 0000950170-24-091769
2024-07-02
Form 8-K
ID: 0000950170-24-080026
2024-06-18
Form 8-K
ID: 0000950170-24-074952
2024-05-29
Form 8-K
ID: 0000950170-24-065636
2024-05-07
Form 10-Q
ID: 0000950170-24-053964
2024-05-07
Form 8-K
ID: 0000950170-24-053963
2024-03-21
Form 8-K
ID: 0001193125-24-073897
2024-03-12
Form 8-K
ID: 0000950170-24-029926
2024-01-24
Form 8-K
ID: 0001193125-24-013587